Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhong-Zhe Lin

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|May 30, 2013
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapyYu-Yun Shao, Po-Chin Liang, Yao-Ming Wu, et al.
Oncology|February 8, 2012
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinomaYu-Yun Shao, Zhong-Zhe Lin, Chiun Hsu, et al.
BMC Cancer|March 1, 2022
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinomaYu-Yun Shao, Hung-Yang Kuo, Yung-Ming Jeng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2023
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trialJeong Heo, Ja-Der Liang, Chang Won Kim, et al.
Hepatology (Baltimore, Md.)|July 27, 2007
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinomaYen-Shen Lu, Yoko Kashida, Samuel K Kulp, et al.
Lung Cancer (Amsterdam, Netherlands)|November 11, 2008
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatmentChin-Lun Huang, Chih-Hsin Yang, Kun-Huei Yeh, et al.
Clinical and Translational Radiation Oncology|April 14, 2020
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancerWen-Chi Yang, Feng-Ming Hsu, Yu-Hsuan Chen, et al.
Oncology|July 12, 2014
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancerYing-Chun Shen, Chung-Pin Li, Chia-Jui Yen, et al.
Plos One|November 19, 2013
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor sizeZhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, et al.
The Oncologist|April 10, 2020
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib MonotherapyZhong-Zhe Lin, Bang-Bin Chen, Yi-Ping Hung, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|May 30, 2013
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapyYu-Yun Shao, Po-Chin Liang, Yao-Ming Wu, et al.
Oncology|February 8, 2012
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinomaYu-Yun Shao, Zhong-Zhe Lin, Chiun Hsu, et al.
BMC Cancer|March 1, 2022
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinomaYu-Yun Shao, Hung-Yang Kuo, Yung-Ming Jeng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2023
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trialJeong Heo, Ja-Der Liang, Chang Won Kim, et al.
Hepatology (Baltimore, Md.)|July 27, 2007
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinomaYen-Shen Lu, Yoko Kashida, Samuel K Kulp, et al.
Lung Cancer (Amsterdam, Netherlands)|November 11, 2008
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatmentChin-Lun Huang, Chih-Hsin Yang, Kun-Huei Yeh, et al.
Clinical and Translational Radiation Oncology|April 14, 2020
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancerWen-Chi Yang, Feng-Ming Hsu, Yu-Hsuan Chen, et al.
Oncology|July 12, 2014
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancerYing-Chun Shen, Chung-Pin Li, Chia-Jui Yen, et al.
Plos One|November 19, 2013
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor sizeZhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, et al.
The Oncologist|April 10, 2020
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib MonotherapyZhong-Zhe Lin, Bang-Bin Chen, Yi-Ping Hung, et al.
Pageof 7